![Joël Richard](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profilo
Joël Richard is currently a member of the Scientific & Medical Council at GlioCure SAS.
He previously worked as the Managing Director at OctreoPharm Sciences GmbH, Development Director at Ipsen Dreux, and Senior Vice President-Pharma Development at Ipsen SA. He is also currently serving as the Chief Scientific Officer at MedinCell SA, a position he has held since 2022 and will continue until 2023.
Posizioni attive di Joël Richard
Società | Posizione | Inizio |
---|---|---|
GlioCure SAS
![]() GlioCure SAS BiotechnologyHealth Technology GlioCure SAS is a French biopharmaceutical company that focuses on discovering and developing new drugs to treat glioma and pediatric brain tumors. The private company is based in Angers, France. | Corporate Officer/Principal | - |
Precedenti posizioni note di Joël Richard
Società | Posizione | Fine |
---|---|---|
MEDINCELL S.A. | Direttore Tecnico/Scientifico/R&S | 01/02/2023 |
IPSEN | Corporate Officer/Principal | - |
Ipsen Dreux | Corporate Officer/Principal | - |
OctreoPharm Sciences GmbH
![]() OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology OctreoPharm Sciences GmbH develops and manufactures pharmaceutical products. It operates as a clinical development biopharmaceutical company which focuses on radiopharmaceuticals for the diagnosis and therapeutic control of tumors. The company was founded by Hakim Larbi Bouterfa and Udo Blaseg in 2010 and is headquartered in Berlin, Germany. | Amministratore Delegato | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
IPSEN | Health Technology |
MEDINCELL S.A. | Health Technology |
Aziende private | 3 |
---|---|
OctreoPharm Sciences GmbH
![]() OctreoPharm Sciences GmbH Pharmaceuticals: MajorHealth Technology OctreoPharm Sciences GmbH develops and manufactures pharmaceutical products. It operates as a clinical development biopharmaceutical company which focuses on radiopharmaceuticals for the diagnosis and therapeutic control of tumors. The company was founded by Hakim Larbi Bouterfa and Udo Blaseg in 2010 and is headquartered in Berlin, Germany. | Health Technology |
GlioCure SAS
![]() GlioCure SAS BiotechnologyHealth Technology GlioCure SAS is a French biopharmaceutical company that focuses on discovering and developing new drugs to treat glioma and pediatric brain tumors. The private company is based in Angers, France. | Health Technology |
Ipsen Dreux |
- Borsa valori
- Insiders
- Joël Richard